Genilume is a technology-first pharmaceutical company developing a comprehensive GenAI platform to repurpose existing therapeutics and transform precision oncology.
Our proprietary AI platform leverages pre-clinical and clinical data to find new uses and indications for existing drugs-- everything from biologics to small molecules, combination therapies, and more.
Clinical Trial Enhancement
Our platform can predict therapeutic efficacy in individual patients before a clinical trial even begins-- Use it to match patients to trials and improve outcomes for everyone involved.
Precision Medicine & Diagnostic Tools
We partner with health-tech organizations to develop specialized AI tools capable of delivering actionable patient insights and therapeutic recommendations from a secure, HIPAA-compliant platform.
Patient Advocacy
At Genilume, we believe every individual deserves access to the latest healthcare technology and treatment options. Please contact us if you are part of a patient advocacy organization interested in partnering with us.
Genilume was founded by a team of scientists and engineers who sought to revolutionize precision medicine and the treatment of complex diseases. Uniting shared passions for healthcare and innovation with a commitment to excellence, Genilume was built on a foundation of strong core values and a vision for a new era of healthcare.